$9.75
-0.64-6.16%
At close: -
$10.23
0.484.92%
After Hours: 7:41 PM EDT
Comments
Loading...
10x Genomics Earnings Estimates, EPS & Revenue | NASDAQ:TXG | Benzinga
10x Genomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 29
EPS Estimate
$-0.190
Quarterly Revenue Estimate
$142.21M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$610.78M
Analyze the earnings history of 10x Genomics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TXG | 10x Genomics | -$0.50 | -$0.19 | — | — | $141.01M | $142.21M | — | — | 04/29/2025 | Get Alert |
| TXG | 10x Genomics | -$0.24 | -$0.11 | -$0.40 | -263.64% | $183.98M | $164.98M | $165.02M | 0.02% | 02/12/2025 | Get Alert |
| TXG | 10x Genomics | -$0.79 | -$0.34 | -$0.30 | 11.76% | $153.64M | $158.63M | $151.65M | -4.40% | 10/29/2024 | Get Alert |
| TXG | 10x Genomics | -$0.53 | -$0.47 | -$0.32 | 31.91% | $146.82M | $150.74M | $153.10M | 1.57% | 08/08/2024 | Get Alert |
| TXG | 10x Genomics | -$0.44 | -$0.50 | -$0.50 | 0.00% | $134.28M | $142.24M | $141.01M | -0.87% | 04/30/2024 | Get Alert |
| TXG | 10x Genomics | -$0.15 | -$0.36 | -$0.24 | 33.33% | $156.23M | $182.80M | $183.98M | 0.64% | 02/15/2024 | Get Alert |
| TXG | 10x Genomics | -$0.37 | -$0.46 | -$0.44 | 4.35% | $131.07M | $151.26M | $153.64M | 1.58% | 11/02/2023 | Get Alert |
| TXG | 10x Genomics | -$0.57 | -$0.39 | -$0.53 | -35.90% | $114.61M | $138.97M | $146.82M | 5.65% | 08/03/2023 | Get Alert |
| TXG | 10x Genomics | -$0.38 | -$0.37 | -$0.44 | -18.92% | $114.50M | $128.82M | $134.28M | 4.24% | 05/03/2023 | Get Alert |
| TXG | 10x Genomics | -$0.16 | -$0.31 | -$0.15 | 51.61% | $143.53M | $148.69M | $156.23M | 5.07% | 02/15/2023 | Get Alert |
| TXG | 10x Genomics | -$0.15 | -$0.46 | -$0.37 | 19.57% | $125.30M | $129.58M | $131.07M | 1.15% | 11/02/2022 | Get Alert |
| TXG | 10x Genomics | -$0.10 | -$0.39 | -$0.57 | -46.15% | $115.84M | $117.19M | $114.61M | -2.20% | 08/08/2022 | Get Alert |
| TXG | 10x Genomics | -$0.11 | -$0.31 | -$0.38 | -22.58% | $105.82M | $113.34M | $114.50M | 1.02% | 05/04/2022 | Get Alert |
| TXG | 10x Genomics | -$0.08 | -$0.09 | -$0.16 | -77.78% | $112.22M | $148.53M | $143.53M | -3.37% | 02/16/2022 | Get Alert |
| TXG | 10x Genomics | -$0.65 | -$0.20 | -$0.15 | 25.00% | $71.82M | $122.62M | $125.30M | 2.18% | 11/03/2021 | Get Alert |
| TXG | 10x Genomics | -$0.41 | -$0.26 | -$0.10 | 61.54% | $42.91M | $112.85M | $115.84M | 2.65% | 08/04/2021 | Get Alert |
| TXG | 10x Genomics | -$0.22 | -$0.27 | -$0.11 | 59.26% | $71.91M | $102.51M | $105.82M | 3.23% | 05/05/2021 | Get Alert |
| TXG | 10x Genomics | -$0.07 | -$0.23 | -$0.08 | 65.22% | $75.29M | $100.40M | $112.22M | 11.77% | 02/17/2021 | Get Alert |
| TXG | 10x Genomics | -$0.33 | -$0.30 | -$0.65 | -116.67% | $61.21M | $61.23M | $71.82M | 17.29% | 11/10/2020 | Get Alert |
| TXG | 10x Genomics | — | -$0.55 | -$0.41 | 25.45% | $55.80M | $29.56M | $42.91M | 45.15% | 08/11/2020 | Get Alert |
| TXG | 10x Genomics | — | -$0.13 | -$0.22 | -69.23% | — | $73.42M | $71.91M | -2.06% | 05/11/2020 | Get Alert |
10x Genomics (TXG) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-12 | $-0.40 | $-0.11 | -263.6 % |
| Q3 | 2024-10-29 | $-0.30 | $-0.34 | 11.8 % |
| Q2 | 2024-08-08 | $-0.32 | $-0.47 | 31.9 % |
| Q1 | 2024-04-30 | $-0.50 | $-0.50 | 0.00 % |
10x Genomics (TXG) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-12 | $165.02M | $164.98M | 0.02 % |
| Q3 | 2024-10-29 | $151.65M | $158.63M | -4.40 % |
| Q2 | 2024-08-08 | $153.10M | $150.74M | 1.57 % |
| Q1 | 2024-04-30 | $141.01M | $142.24M | -0.87 % |
FAQ
When is 10x Genomics (NASDAQ:TXG) reporting earnings?
10x Genomics (TXG) is scheduled to report earnings on April 29, 2025. The last reported earnings were for reported on February 12, 2025 for Q4.
What were the latest earnings per share (EPS) for 10x Genomics (NASDAQ:TXG)?
The Actual EPS was $-0.40, which missed the estimate of $-0.11.
What were 10x Genomics’s (NASDAQ:TXG) revenues?
The Actual Revenue was $165M, which beat the estimate of $165M.
Browse earnings estimates, EPS, and revenue on all stocks.